THE ANTI-DIABETIC POTENTIAL OF MUSHROOMS: A REVIEW

The Anti-Diabatic Mushrooms

Authors

  • Waill Elkhateeb Assistance professor in Chemistry of Natural and Microbial Products Department, Pharmaceutical Industries Institute, National Research Centre, Dokki, Giza, 12622, Egypt.
  • Galappaththi MCA Professor of Postgraduate Institute of Science (PGIS), University of Peradeniya, Peradeniya, Sri Lanka
  • dina elghwas -national research center
  • Ghoson Daba Assistance professor in Chemistry of Natural and Microbial Products Department, Pharmaceutical Industries Institute, National Research Centre, Dokki, Giza, 12622, Egypt.

DOI:

https://doi.org/10.55766/sujst-2023-06-e01521

Keywords:

biological activities, fungi, medicinal mushrooms, secondary metabolites

Abstract

It is crucial to discover new nutraceuticals or medications to cure or prevent diabetes because it is becoming a pandemic. Some mushrooms seem to have benefits in controlling blood glucose levels and correcting diabetes problems without any negative side effects. Only a few regions employ mushrooms as appetizing food, health-improving dietary supplements, or medicine because they contain immune-modulating polysaccharides. However, scientific or clinical research on mushrooms has not been sufficient to allow them to be used as recognized medicines or nutraceuticals worldwide. These functional fungi may have a greater impact on the prevention and diabetes treatment. This review focuses on prospective mushrooms that have demonstrated anti-diabetic effects in clinical or experimental studies and prevent or slow the progression of diabetes mellitus.

References

Abou Zaid, O.A., Sonbaty, S.E., and Neama, M.A. (2017). Anti-diabetic activity of Agaricus bisporus: A biochemical and pathological study.‏ Int. J. Pharm. Sci., 7(2):1,740-1,745.

Ajith, T.A. and Janardhanan, K.K. (2021). Antidiabetic properties of medicinal mushrooms with special reference to Phellinus species: A review. The Natural Products Journal, 11(2):120-126.‏ DOI: 10.2174/2210315510666200124124540.

Bach, E.E., Costa, S.G., Oliveira, H.A., Junior, J.S., da Silva, K.M., de Marco, R.M., and Wadt, N.S. (2015). Use of polysaccharide extracted from Tremella fuciformis berk for control diabetes induced in rats. Emirates Journal of Food and Agriculture, 27(7):585-591.‏ DOI: https://doi.org/10.9755/ejfa.2015.

Badalyan, S.M., Barkhudaryan, A., and Rapior, S. (2019). Recent progress in research on the pharmacological potential of mushrooms and prospects for their clinical application. In: Medicinal Mushrooms. Agrawal, D., and Dhanasekaran, M. (Eds). Springer, Singapore, 1-70.‏ DOI: 10.1007/978-981-13-6382-5_1.

Begum, N., Nasir, A., Parveen, Z., Muhammad, T., Ahmed, A., Farman, S., and Batiha, G.E. (2021). Evaluation of the hypoglycemic activity of Morchella conica by targeting protein tyrosine phosphatase 1B. Front. Pharmacol., 12:1,148.‏ DOI: 10.3389/fphar.2021.661803.

Cao, H., Qin, D., Guo, H., Cui, X., Wang, S., Wu, Y., Zheng, W., Zhong, X., Wang, H., Yu, J., Zhang, H., and Han, C. (2020). The shaggy ink cap medicinal mushroom, Coprinus comatus (Agaricomycetes), a versatile functional species: A review. International journal of medicinal mushrooms, 22(3):245-255. DOI: 10.1615/IntJMedMushrooms.2020033988.

Chen, H., Lu, X., Qu, Z., Wang, Z. and Zhang, L. (2010). Glycosidase inhibitory activity and antioxidant properties of a polysaccharide from the mushroom Inonotus obliquus. Journal of Food Biochemistry, 34:178-191. DOI: 10.1111/j.1745-4514.2009. 00322.x

Chowdhury, P., and Paul, S. (2020). The potential role of mushrooms in the prevention and treatment of diabetes: A review. Journal of Biologically Active Products from Nature, 10(5):429-454.‏ DOI: 10.1080/22311866.2020.1831958.

Daba, G., and Elkhateeb, W.A. (2020). The endless nutritional and pharmaceutical benefits of the Himalayan gold, Cordyceps; Current knowledge and prospective potentials. Asian J. Nat, Prod, Biochem, 18(2):1-8.‏ DOI: 10.13057/biofar/f180204.

Daba, G.M., Elkhateeb, W., ELDien, A.N., Fadl, E., Elhagrasi, A., Fayad, W., and Wen, T.C. (2020). Therapeutic potentials of n-hexane extracts of the three medicinal mushrooms regarding their anti-colon cancer, antioxidant, and hypocholesterolaemia capabilities. Biodiversitas, 21(6):1-10.‏ DOI: 10.13057/biodiv/d210615.

De Silva, D.D., Rapior, S., Hyde, K.D., and Bahkali, A.H. (2012). Medicinal mushrooms in prevention and control of diabetes mellitus. Fungal Diversity, 56(1):1-29.‏ DOI: 10.1007/s13225-012-0187-4.

Ding, Z., Lu, Y., Lu, Z., Lv, F., Wang, Y., Bie, X., and Zhang, K. (2010). Hypoglycaemic effect of comatic, an antidiabetic substance separated from Coprinus comatus broth, on alloxan-induced-diabetic rats.Food Chemistry, 121(1):39-43.‏ DOI: 10.1016/j.foodchem.2009.12.001.

Dong, Y., Jing, T., Meng, Q., Liu, C., Hu, S., Ma, Y., and Teng, L. (2014). Studies on the antidiabetic activities of Cordyceps militaris extract in diet-streptozotocin-induced diabetic Sprague-Dawley rats. Biomed. Res. Int., 1-10.‏ DOI: 10.1155/2014/160980.

Dotan, N., Wasser, S.P., and Mahajna, J. (2011). The culinary‐medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator. Integr. Cancer Ther., 10(2):148-159. DOI: 10.1177/1534735410383169.

Du, B. and Xu, B. (2014). An insight into anti-diabetic effects of mushrooms. In: Mushrooms: Cultivation, antioxidant properties and health benefits. Pesti, G. (Eds.). New York: Nova Science Publishers, 141-155.‏

Ekowati, N., Yuniati, N., Hernayanti, H., and Ratnaningtyas, N. (2018). Antidiabetic potentials of button mushroom (Agaricus bisporus) on alloxan-induced diabetic rats. Biosaintifika, 10(3):655-662.‏ DOI: 10.15294/biosaintifika. v10i3.17126.

Elkhateeb, W., Thomas, P., Elnahas, M., and Daba, G. (2021a). Hypogeous and epigeous mushrooms in human health. In: Advances in Macrofungi. Sridhar, K.R., and Deshmukh, S.K. (Eds.). CRC Press, Boca Raton, 7-19. DOI: 10.1201/9781003191278-2.

Elkhateeb, W.A. (2020). What medicinal mushroom can do. Chem. Res. J., 5(1):106-118.

Elkhateeb, W.A., and Daba, G.M. (2021a). Highlights on the golden mushroom Cantharellus cibarius and unique shaggy ink cap mushroom Coprinus comatus and smoky bracket mushroom Bjerkandera adusta ecology and biological activities. J. Mycol. Mycological Sci., 4(2):1-8. DOI: 10.23880/oajmms-16000143.

Elkhateeb, W.A., and Daba, G.M. (2021b). Mycotherapy of the good and the tasty medicinal mushrooms Lentinus, Pleurotus, and Tremella.‏ J. Pharmaceutics and Pharmacology Research, 4(3):1-6. DOI: 10.31579/2693-7247/029.

Elkhateeb, W.A., Daba, G.M., El-Dein, A.N, Sheir, D.H., Fayad, W., Shaheen, M.N., and Wen, T.C. (2020). Insights into the in-vitro hypocholesterolaemia, antioxidant, antirotavirus, and anticolon cancer activities of the methanolic extracts of a Japanese lichen, Candelariella vitellina, and a Japanese mushroom, Ganoderma applanatum. Egypt. Pharm. J., 19(1):67.‏ DOI: 10.4103/epj.epj_56_19.

Elkhateeb, W.A., Daba, G.M., Thomas, P.W., and Wen, T.C. (2019). Medicinal mushrooms as a new source of natural therapeutic bioactive compounds. Egypt. Pharm. J., 18(2):88-101.‏ DOI: 10.4103/epj.epj_17_19.

Elkhateeb, W.A., El Ghwas, D.E., Gundoju, N.R., Somasekhar, T., Akram, M., and Daba, G.M. (2021b). Chicken of the woods Laetiporus Sulphureus and Schizophyllum commune treasure of medicinal mushrooms. J. Microbiol. Biotechnol., 6(3):1-7. DOI: 10.23880/oajmb-16000201.

Elkhateeb, W.A., El-Hagrassi, A.M., Fayad, W., El-Manawaty, M.A., Zaghlol, G.M., Daba, G.M., and Ahmed, E.F. (2018). Cytotoxicity and hypoglycemic effect of the Japanese jelly mushroom Auricularia auricula-judae. Chemistry Research Journal, 3:123-133.

Friedman, M. (2016). Mushroom polysaccharides: chemistry and antiobesity, antidiabetic, anticancer, and antibiotic properties in cells, rodents, and humans. Foods, 5(4):80.‏ DOI: 10.3390/foods5040080.

Hsu, C.H., Liao, Y.L., Lin, S.C., Hwang, K.C., and Chou, P. (2007). The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes:

a randomized, double-blinded, and placebo-controlled clinical trial. J. Altern. Complement Med., 13(1):97-102. DOI: 10.1089/acm.2006.6054.

Huang, Q., Chen, L., Teng, H., Song, H., Wu, X., and Xu, M. (2015). Phenolic compounds ameliorate the glucose uptake in HepG2 cells’ insulin resistance via activating AMPK. J. Funct. Foods, 19:487-494. DOI: 10.1016/j.jff.2015.09.020.

Husen, F., Hernayanti, H., Ekowati, N., Sukmawati, D., and Ratnaningtyas, N.I. (2021). Antidiabetic effects and antioxidant properties of the saggy ink cap medicinal mushroom, Coprinus comatus (Agaricomycetes), in streptozotocin-induced hyperglycemic rats. Int. J. Med. Mushrooms, 23(10):9-21. DOI: 10.1615/IntJMedMushrooms.2021040020.

Jang, J.S., Lee, J.S., Lee, J.H., Kwon, D.S., Lee, K.E., Lee, S.Y., and Hong E.K. (2010). Hispidin produced from Phellinus linteus protects pancreatic β-cells from damage by hydrogen peroxide. Arch. Pharm. Res., 33:853-861. DOI: 10.1007/s12272-010-0607-5.

Jeong, S., Jeong, Y., Yang, B., Islam, R., Koyyalamudi, S., Pang, G., and Song, C.H. (2010). White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr. Res., 30(1):49-56.‏ DOI: 10.1016/j.nutres.2009.12.003.

Jovanovi´c, J.A., Mihailovi´c, M., Uskokovi´c, A., Grdovi´c, N., Dini´c, S., and Vidakovi´c, M. (2021). The effects of major mushroom bioactive compounds on mechanisms that control blood glucose level. J. Fungi., 7(58):1-15. Doi: 10.3390/jof7010058.

Jung, S.H., Lee, Y.S., Shim, S.H., and Lee, S. (2005). Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues. Phytother. Res., 19:477-480. DOI: 10.1002/ptr.1638.

Kiho, T., Kochi, M., Usui, S., Hirano, K., Aizawa, K., and Inakuma, T. (2001). Antidiabetic effect of an acidic polysaccharide (TAP) from Tremella aurantia and its degradation product (TAP-H). Biol. Pharm. Bull., 24(12):1,400-1,403. DOI: 10.1248/bpb.24.1400.

Kim, H.M., Kang, J.S., Kim, J.Y., Park, S.K., Kim, H.S., Lee, Y.J., and Han, S.B. (2010). Evaluation of antidiabetic activity of polysaccharide isolated from Phellinus linteus in non-obese diabetic mouse. Int. Immunopharmacol., 10(1):72-78.‏ DOI: 10.1016/j.intimp.2009.09.024.

Kou, L., Du, M., Liu, P., Zhang, B., Zhang, Y., Yang, P., and Wang, X. (2019). Anti-diabetic and anti-nephritic activities of Grifola frondosa mycelium polysaccharides in diet-streptozotocin-induced diabetic rats via modulation on oxidative stress. Appl. Biochem. Biotechnol., 187(1):310-322.‏ DOI: 10.1007/s12010-018-2803-6.

Kubo, K., Aoki, H., and Nanba, H. (1994). Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). I. Biol Pharm. Bull., 17(8):1,106-1,110.‏ DOI: 10.1248/bpb.17.1106.

Ma, H.T., Hsieh, J.F., and Chen, S.T. (2015). Anti-diabetic effects of Ganoderma lucidum. Phytochemistry, 114:109-113.‏ DOI: 10.1016/j.phytochem.2015.02.017.

Niwa, A., Tajiri, T., and Higashino, H. (2011). Ipomoea batatas and Agarics blazei ameliorate diabetic disorders with therapeutic antioxidant potential in streptozotocin-induced diabetic rats. J. Clin. Biochem. Nutr., 48:194-202. DOI: 10.3164/jcbn.10-78.

Nowakowski, P., Naliwajko, S.K., Markiewicz‐Żukowska, R., Borawska, M.H., and Socha, K. (2020). The two faces of Coprinus comatus-Functional properties and potential hazards. Phytother. Res., 34(11):2,932-2,944. DOI: 10.1002/ptr.6741.

Nyam, K.L., Chow, C.F., Tan, C.S., and Ng, S.T. (2017). Antidiabetic properties of the tiger’s milk medicinal mushroom, Lignosus rhinocerotis (Agaricomycetes), in streptozotocin-induced diabetic rats. Int. J. Med. Mushrooms, 19(7):607-617. DOI: 10.1615/IntJMedMushrooms.2017021186.

Patel, Y., Naraian, R., and Singh, V.K. (2012). Medicinal properties of Pleurotus species (oyster mushroom): A review. World J. Fungal & Plant Biol., 3(1):1-12.‏ DOI: 10.5829/idosi.wjfpb.2012.3.1.303.

Paterson, R.R. (2008). Cordyceps-A traditional Chinese medicine and another fungal therapeutic bio factory? Phytochemistry, 69(7):1,469-1,495.‏ DOI: 10.1016/j.phytochem.2008.01.027.

Patocka, J. (2019). Will the sulphur polypore (Laetiporus sulphureus) become a new functional food? Global Journal of Medical and Clinical Case Reports, 6(1):6-9.‏

Peng, H., and Shahidi, F. (2020). Bioactive compounds and bioactive properties of chaga (Inonotus obliquus) mushroom: A review. Journal of Food Bioactives, 12:9-75. DOI: org/10.31665/JFB.2020.12245.

Perera, P.K. and Li, Y. (2011). Mushrooms as a functional food mediator in preventing and ameliorating diabetes. J. Funct. Food Health Dis., 1(4):161-171.‏ DOI: 10.31989/ffhd.v1i4.133

Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., and Bitto, A. (2017). Oxidative stress: harms and benefits for human health. Oxid. Med. Cell Longev., 2017:8416763. DOI: 10.1155/2017/8416763.

Rašeta, M., Popović, M., Čapo, I., Stilinović, N., Vukmirović, S., Milošević, B., and Karaman, M. (2020). Antidiabetic effect of two different Ganoderma species tested in alloxan diabetic rats. Rsc. Advances, 10(17):10,382-10,393.‏ DOI: 10.1039/c9ra10158f.

Ratnaningtyas, N.I., Hernayanti, H., Ekowati, N., and Husen, F. (2022). Ethanol extract of the mushroom Coprinus comatus exhibits antidiabetic and antioxidant activities in streptozotocin-induced diabetic rats. Pharm. Biol., 60(1):1,126-1,136. DOI: 10.1080/13880209.2022.2074054.

Sękowski, K., Grudziąż-Sękowska, J., Pinkas, J., and Jankowski, M. (2022). Public knowledge and awareness of diabetes mellitus, its risk factors, complications, and prevention methods among adults in Poland-A 2022 nationwide cross-sectional survey. Front. Public Health., 10:1029358. DOI: 10.3389/fpubh.2022.1029358.

Sun, J. E., Ao, Z. H., Lu, Z.M., Xu, H.Y., Zhang, X.M., Dou, W.F., and Xu, Z.H. (2008). Antihyperglycemic and anti-lipid peroxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. J. Ethnopharmacol., 118(1):7-13. DOI: 10.1016/j.jep.2008.02.030.

Szychowski, K.A., Skóra, B., Pomianek, T., and Gmiński, J. (2021). Inonotus obliquus - from folk medicine to clinical use. J. Tradit. Complement. Med., 11:293-302. DOI: 10.1016/j.jtcme.2020.08.003.

Thomas, P.W., Elkhateeb, W.A., and Daba, G.M. (2020). Chaga (Inonotus obliquus): A medical marvel but a conservation dilemma. Sydowia, 72:123-130.‏ DOI 10.12905/0380.sydowia72-2020-0123.

Wang, C., Chen, Z., Pan, Y., Gao, X., and Chen, H. (2017). Anti-diabetic effects of Inonotus obliquus polysaccharides-chromium (III) complex in type 2 diabetic mice and its sub-acute toxicity evaluation in normal mice. Food Chem. Toxicol., 108:498-509. DOI: 10.1016/j.fct.2017.01.007.

Wińska, K., Mączka, W., Gabryelska, K., and Grabarczyk, M. (2019). Mushrooms of the genus Ganoderma used to treat diabetes and insulin resistance. Molecules, 24(22):4,075.‏ DOI: 10.3390/molecules24224075.

Wu, S.J., Tung, Y.J., and Ng, L.T. (2020). Anti-diabetic effects of Grifola frondosa bioactive compound and its related molecular signalling pathways in palmitate-induced C2C12 cells. J. Ethnopharmacol., 260:112962. DOI: 10.1016/j.jep.2020.112962.

Wu, T., and Xu, B.B. (2015). Antidiabetic and antioxidant activities of eight medicinal mushroom species from China. International Journal of Medicinal Mushrooms, 17(2):1-10.‏ DOI: 10.1615/IntJMedMushrooms.v17. i2.40.

Xiao, C., Wu, Q.P., Cai, W., Tan, J.B., Yang, X.B., and Zhang, J.M. (2012). Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice. Arch. Pharm. Res., 35(10):1,793-801. DOI: 10.1007/s12272-012-1012-z.

Yang, K., Zhang, S., Ying, Y., Li, Y., Cai, M., Guan, R., Sun, P. (2020). Cultivated fruit body of Phellinus baumii: A potentially sustainable antidiabetic resource. ACS Omega, 5(15):8596-8604.‏ DOI: 10.1021/acsomega.9b04478.

Zhang, G., Huang, Y., Bian, Y., Wong, J.H., Ng, T.B., and Wang, H. (2006). Hypoglycemic activity of the fungi Cordyceps militaris, Cordyceps sinensis, Tricholoma mongolicum, and Omphalia lapidescens in streptozotocin-induced diabetic rats. Appl. Microbiol. Biotechnol., 72(6):1,152-1,156.‏ DOI: 10.1007/s00253-006-0411-9.

Downloads

Published

2024-02-09

How to Cite

Elkhateeb, W., Galappaththi, M., elghwas, dina, & Daba, G. (2024). THE ANTI-DIABETIC POTENTIAL OF MUSHROOMS: A REVIEW: The Anti-Diabatic Mushrooms. Suranaree Journal of Science and Technology, 30(6), 030155(1–9). https://doi.org/10.55766/sujst-2023-06-e01521

Issue

Vol. 30 No. 6 (2023): November - December

Section

Review Article

Categories